| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:18 | Modular Medical secures payer agreements covering 182M lives | 2 | Investing.com | ||
| 15:02 | Modular Medical, Inc.: Modular Medical Secures Coverage Agreements with All Three of the Nation's Largest PBMs for Pivot Insulin Delivery System | 263 | ACCESS Newswire | Agreements Expand Upon Previously Announced Coverage and Establish Broad Access Across Commercial, Medicare, and Medicaid PlansPBM Networks Collectively Cover More Than 182 Million Lives and Process... ► Artikel lesen | |
| Di | Modular Medical, Inc.: Modular Medical CEO Jeb Besser to Discuss Pivot Commercial Updates in Virtual Fireside Chat on November 19th | 203 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / November 17, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 09.11. | Modular Medical, Inc.: Modular Medical Completes Comprehensive Patient Market Research Study with Thrivable, Reinforcing Strong Interest in Simplified Insulin Delivery | 213 | ACCESS Newswire | More Than 540 People with Diabetes Participated in a Three-Phase Study of Treatment Burden, Pump Adoption Barriers and Perceptions of the Pivot Tubeless Patch PumpNine out of 10 MDI Users Said They... ► Artikel lesen | |
| 29.10. | Modular Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 28.10. | Modular Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.10. | Modular Medical, Inc.: Modular Medical Announces Positive Notified Body Decision on ISO 13485:2016 Certification | 626 | ACCESS Newswire | Certification Represents Another Milestone Toward CE Mark Submission for Pivot SAN DIEGO, CA / ACCESS Newswire / October 27, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD)... ► Artikel lesen | |
| 15.10. | Modular Medical launches digital tools for insulin pump training | 2 | Investing.com | ||
| 15.10. | Modular Medical, Inc.: Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System | 300 | ACCESS Newswire | Game-Based Education Tools Designed to Help Improve Patient Familiarity with Pump Therapy and Support Healthcare Providers in Identifying Candidates for Pump Adoption SAN DIEGO, CA / ACCESS Newswire... ► Artikel lesen | |
| 07.10. | Modular Medical, Inc.: Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th | 313 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / October 7, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 29.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.09. | Modular Medical, Inc.: Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026 | 393 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.09. | Modular Medical Aktie steigt nach Vertrag mit führendem Pharmacy Benefit Manager | 2 | Investing.com Deutsch | ||
| 04.09. | Modular Medical sichert sich Vertrag mit landesweitem US-Apothekenmanager | 1 | Investing.com Deutsch | ||
| 04.09. | Modular Medical secures contract with national U.S. pharmacy manager | 2 | Investing.com | ||
| 04.09. | Modular Medical, Inc.: Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump | 517 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial... ► Artikel lesen | |
| 03.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09. | Modular Medical, Inc.: Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements | 445 | ACCESS Newswire | Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization SAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / Modular Medical, Inc. ("Modular Medical" or "the... ► Artikel lesen | |
| 03.09. | EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades | 2 | Benzinga.com | ||
| 02.09. | Modular Medical, Inc.: Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled 'The Road To Revenue: Modular Medical's Strategy For Launching Pivot' Featuring Modular Medical CEO - Friday, September 4, 2026 | 503 | ACCESS Newswire | Meet with Modular Medical CEO Jeb Besser.Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,166 | -2,48 % | Truist raises Teladoc stock price target to $9 on EBITDA outlook | ||
| SERNOVA BIOTHERAPEUTICS | 0,059 | -9,76 % | Sernova Biotherapeutics: 11,2 Millionen Dollar für die Fusion - und doch rutscht die Aktie | ||
| CERENOME | 0,585 | +23,55 % | Cerenome outlines $10M-$12.5M 2026 gross billings run rate exit while targeting mid-2027 REYOBIQ top line data | ||
| ATOSSA THERAPEUTICS | 1,640 | -1,20 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Rekord bei Umsatz und Gewinn - lächerliche Bewertung! | Sonoma Pharmaceuticals macht den nächsten gewaltigen Schritt auf dem Weg zum profitablen Wachstumsunternehmen. Nach dem erstmaligen Erreichen eines positiven EBITDA im Vorquartal meldet der Healthcare-Spezialist... ► Artikel lesen | |
| TANDEM DIABETES | 15,500 | -0,64 % | Warum die Aktie von Tandem Diabetes Care heute kräftig zulegt | ||
| CO-DIAGNOSTICS | 0,169 | -14,77 % | Co-Diagnostics receives test order from Peru amid dengue rise | ||
| QUIDELORTHO | 8,994 | +2,98 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,120 | -7,83 % | Veru presents data on enobosarm for obesity treatment | ||
| LIFEWARD | 3,210 | +0,31 % | Lifeward GAAP EPS of -$1.32 misses by $0.50, revenue of $5.43M misses by $1.81M | ||
| CLOVER HEALTH INVESTMENTS | 3,580 | -5,79 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| SENSEONICS | 8,800 | -1,12 % | Beta Bionics, Inc.: Senseonics and Beta Bionics Launch Eversense 365 and iLet Bionic Pancreas Integration | ||
| TEMPEST THERAPEUTICS | 0,307 | -6,08 % | Tempest Therapeutics GAAP EPS of -$0.21 beats by $0.11 | ||
| NANO-X IMAGING | 0,242 | -15,79 % | NANO-X IMAGING LTD: Nanox to Showcase Its Innovative Technology and Advances Across Nanox.ARC X and Nanox.AI at RSNA 2026 | ||
| IMUNON | 0,430 | -2,27 % | Imunon targets 50% OVATION-3 enrollment in Q1 2028 while aiming for interim analysis in Q1 2030 |